Weekly Digest: New diabetes clinical trial (18 items)

New diabetes clinical trial: The Pharmacokinetics, Safety and Tolerability of IN-C009 in Healthy Subjects Published on: October 04, 2021 at 07:00PM Condition:   Diabetes Mellitus Intervention:   Drug: FCDP, dapagliflozin 10mg/linagliptin 5 mg or co-administration of a single dose of dapagliflozin and linagliptin Sponsor:   Korea University Anam Hospital Completed https://clinicaltrials.gov/ct2/show/NCT05066516?term=diabetes&sfpd_d=14 October 04, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: Pediatric Boot Camp Program Published on: October 04, 2021 at 07:00PM Conditions:   Type 1 Diabetes;   Children, Only Intervention:   Other: telehealth visits Sponsor:   Georgetown University Recruiting https://clinicaltrials.gov/ct2/show/NCT05066893?term=diabetes&sfpd_d=14 October 04, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: Evaluation of Immunogenicity and Safety of COVAX (Produced in Wuhan) in Patients With Hypertension and/or Diabetes Published on: October 04, 2021 at 07:00PM Condition:   COVID-19 Pneumonia Intervention:   Biological: COVAX Sponsors:   China National Biotec Group Company Limited;   Guizhou Center for Disease Control and Prevention;   Hunan Center for Disease Control and Prevention;   Fujian Center for Disease Control and Prevention;   Wuhan Institute of Biological Products Co., Ltd Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05065892?term=diabetes&sfpd_d=14 October 04, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: Evaluation of Immunogenicity and Safety of COVAX (Produced in Beijing) in Patients With Hypertension and/or Diabetes Published on: October 04, 2021 at 07:00PM Condition:   COVID-19 Pneumonia Intervention:   Biological: COVAX Sponsors:   China National Biotec Group Company Limited;   Hunan Center for Disease Control and Prevention;   Guizhou Center for Disease Control and Prevention;   Fujian Center for Disease Control and Prevention;   Beijing Institute of Biological Products Co Ltd. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05065879?term=diabetes&sfpd_d=14 October 04, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: The Effect of Single Probiotic on Metabolic Control in Type 2 Diabetes Published on: October 04, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Dietary Supplement: Lactobacillus rhamnosus GG (ATCC 53103);   Dietary Supplement: Placebo Sponsor:   Istanbul University Completed https://clinicaltrials.gov/ct2/show/NCT05066152?term=diabetes&sfpd_d=14 October 04, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes Published on: October 04, 2021 at 07:00PM Conditions:   Type 1 Diabetes;   Diabetic Kidney Disease;   Cardiovascular Diseases;   Endothelial Dysfunction;   Insulin Sensitivity Interventions:   Drug: Metformin Hcl 1000Mg Tab;   Drug: Aminohippurate Sodium 20 % Injection;   Drug: Iohexol 300 Mg/mL Injectable Solution;   Drug: Placebo Sponsors:   University of Colorado, Denver;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05065372?term=diabetes&sfpd_d=14 October 04, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: Recreational Basketball to Increase Participation in Diabetes Prevention Published on: October 04, 2021 at 07:00PM Conditions:   Type 2 Diabetes;   PreDiabetes Interventions:   Behavioral: NDPP + Basketball (BB);   Behavioral: NDPP Standard of Care SOC Sponsor:   Kaiser Permanente Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT05066542?term=diabetes&sfpd_d=14 October 04, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: The CGMS in GDM Labor and Delivery Study Published on: October 05, 2021 at 07:00PM Condition:   Gestational Diabetes Mellitus in Pregnancy Intervention:   Device: Blinded CGM Sponsors:   Woman's;   DexCom, Inc. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05067075?term=diabetes&sfpd_d=14 October 05, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Liraglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease Published on: October 05, 2021 at 07:00PM Conditions:   New Onset Type 2 Diabetes in Obese Adolescent;   Impaired Glucose Tolerance in Obese Adolescent;   Non-Alcoholic Fatty Liver Disease in Obese Adolescent Interventions:   Drug: Liraglutide Pen Injector;   Drug: Placebo Sponsors:   Yale University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05067621?term=diabetes&sfpd_d=14 October 05, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus Published on: October 05, 2021 at 07:00PM Condition:   Type 1 Diabetes Mellitus Interventions:   Drug: Sodium Citrate;   Drug: Treprostinil;   Drug: Humalog diluent;   Drug: Magnesium Chloride;   Device: Medtronic™ MiniMed™ 770G pump Sponsor:   Eli Lilly and Company Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05067270?term=diabetes&sfpd_d=14 October 05, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Pilot Trial of the Nutrition-Supported Diabetes Education Program Published on: October 05, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Other: Food support;   Other: Case-management Sponsors:   University of California, San Francisco;   Project Open Hand;   Contra Costa Health Services;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05067452?term=diabetes&sfpd_d=14 October 05, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Simple Initiation of Advanced Hybrid Closed Loop System Published on: October 06, 2021 at 07:00PM Condition:   Diabetes type1 Interventions:   Procedure: Regular Protocol with advanced carbohydrate counting;   Procedure: Simplified Protocol with fixed carbohydrate content Sponsor:   Sidra Medical and Research Center Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05069727?term=diabetes&sfpd_d=14 October 06, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: Assessment of Metabolic Profiles of Lower Extremity Arterial Disease in Patiens Withe Type 2 Diabetes Published on: October 06, 2021 at 07:00PM Conditions:   Diabetic Angiopathies;   Diabetes Mellitus, Type 2 Intervention:   Other: liquid chromatography-mass spectrometry Sponsor:   Zhiming Zhu Recruiting https://clinicaltrials.gov/ct2/show/NCT05068895?term=diabetes&sfpd_d=14 October 06, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice Published on: October 06, 2021 at 07:00PM Condition:   Diabetes Mellitus, Type 1 Interventions:   Drug: Insulin degludec;   Drug: Fast-acting insulin aspart Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05069545?term=diabetes&sfpd_d=14 October 06, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: Self-compassion to Reduce Diabetes Distress in Persons With Type 1 Diabetes Published on: October 07, 2021 at 07:00PM Condition:   Type 1 Diabetes Intervention:   Behavioral: Mindful Self-Compassion Sponsors:   Mahidol University;   Chulalongkorn University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05070949?term=diabetes&sfpd_d=14 October 07, 2021 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: Pharmacogenetics of Response to GLP1R Agonists Published on: October 08, 2021 at 07:00PM Conditions:   Obesity;   Diabetes Type 2 Intervention:   Drug: Semaglutide Pen Injector [Ozempic] Sponsor:   University of Maryland, Baltimore Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05071898?term=diabetes&sfpd_d=14 October 08, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: The Effect of D-allulose on Glycemic Changes in Patients With Type 2 Diabetes Mellitus During Ramadan Fasting Published on: October 08, 2021 at 07:00PM Condition:   Glucose, High Blood Interventions:   Other: Control period;   Dietary Supplement: D-allulose period Sponsors:   Universiti Putra Malaysia;   Matsutani Chemical Industry Co., Ltd.;   Kagawa University Completed https://clinicaltrials.gov/ct2/show/NCT05071950?term=diabetes&sfpd_d=14 October 08, 2021 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Microlearning Application for Diabetes Prevention Published on: October 08, 2021 at 07:00PM Condition:   PreDiabetes Interventions:   Other: Health U mobile application;   Other: National Diabetes Prevention Program Sponsor:   Stanford University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05071820?term=diabetes&sfpd_d=14 October 08, 2021 at 02:22PM via ClinicalTrials.gov